The SMART Stone Multidisciplinary Team (MDT) recommendations aim to provide guidance on the role of the MDT in the early identification, referral and assessment of adult high-risk recurrent kidney stone formers to advance patient care.
Recommendations were developed by the expert Steering Committee (SC) comprising of three Urologists, one Nephrologist, and two Biochemists/Geneticists from the UK, Spain, Germany, and Italy. These recommendations were voted on by invited specialists via an online survey to determine their level of agreement, from 'strongly agree' to 'strongly disagree'. With an agreement threshold set at ≥ 70%, the SC reviewed the survey results, additional comments, and any areas of disagreement before finalizing the recommendations.
A total of 44 recommendations were developed by the SC designed to support the set-up of an ideal MDT. Thirteen core recommendations were chosen as being highest priority and were voted on by 29 invited specialists from 19 countries across Europe, Canada, East Asia, South/Southeast Asia, and the Middle East. All 13 core recommendations reached the ≥ 70% agreement threshold. The remaining 31 recommendations were voted on by those specialists who opted-in to partake in the extended questionnaire. Fifteen specialists provided their responses from 14 different countries. All 31 recommendations reached the ≥ 70% agreement threshold.
An ideal MDT process can achieve comprehensive, high-quality, and coordinated patient care, which is especially useful for patients with complex stone diseases. A high level of agreement was reached in areas relating to the implementation of an ideal MDT in identifying high-risk stone formers.
World journal of urology. 2025 Apr 22*** epublish ***
Bhaskar Somani, Esteban Emiliani, Thomas Knoll, Giorgia Mandrile, Gill Rumsby, Cecile Acquaviva, Naeem Bhojani, Saeed Bin Hamri, Ewa Bres-Niewada, Niall F Davis, Daniel G Fuster, Sander F Garrelfs, Vineet Gauhar, Shuzo Hamamoto, Patrick Juliebø-Jones, Marta Leporati, Emmanuel Letavernier, Tatsuya Takayama, Lazaros Tzelves, Steffi Kar Kei Yuen, Pietro Manuel Ferraro
SMART Stone Steering Committee, Southampton, UK. ., SMART Stone Steering Committee, Southampton, UK., Service Biochimie et Biologie Moléculaire, Centre de Biologie et Pathologie Est, Unité Maladies Héréditaires du Métabolisme, CHU de Lyon, France., University of Montreal Hospital Center, Université de Montréal, Montreal, QC, Canada., Division of Urology, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Department of Urology, Faculty of Medicine, Roefler Memorial Hospital in Pruszkow, Lazarski University, Warsaw, Poland., Department of Urology, Beaumont Hospital, Dublin, Ireland., Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Department of Pediatric Nephrology, Emma Children'S Hospital, University of Amsterdam, Amsterdam, The Netherlands., Department of Urology, Ng Teng Fong General Hospital, Singapore, Singapore., Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Department of Urology, Haukeland University Hospital, Bergen, Norway., Laboratorio di Chimica Analitica e Calcolosi Renale, SC Laboratorio analisi, Azienda Ospedaliera Ordine Mauriziano di Torino, Turin, Piemonte, Italy., UMR S 1155, Sorbonne Université, 75020, Paris, France., Department of Urology, International University of Health and Welfare Hospital, Nasushiobara, Japan., Department of Urology, Sismanogleio Hospital, National and Kapodistrian University of Athens, Athens, Greece., Department of Surgery, SH Ho Urology Centre, the Chinese University of Hong Kong, Hong Kong SAR, China.